43 results
PRE 14A
LRMR
Larimar Therapeutics Inc
12 Apr 24
Preliminary proxy
6:06am
recruitment and retention of exceptional officer candidates that conclude that the potential exposure to liabilities, costs of defense and other risks
8-K
EX-99.2
LRMR
Larimar Therapeutics Inc
11 Mar 24
Other Events
4:09pm
provides industry with several key items Assistance with patient recruitment and education Access to Global Patient Registry with demographic
424B5
LRMR
Larimar Therapeutics Inc
14 Feb 24
Prospectus supplement for primary offering
5:08pm
potential products;
the recruitment or departure of key personnel;
our sale or proposed sale, or the sale by our significant stockholders, of our … in patient recruitment for our clinical trials (including as a result of the impact of FDA approval of competitive products for the treatment
424B5
923nyjub1m cf
13 Feb 24
Prospectus supplement for primary offering
4:46pm
8-K
EX-99.2
zl2255yt k3a5rxrwx6
12 Feb 24
Results of Operations and Financial Condition
7:03am
8-K
EX-99.2
7v0osxggnmi3qctn0wu7
14 Nov 23
Larimar Therapeutics Reports Third Quarter 2023 Operating and Financial Results
12:00am
8-K
EX-99.1
i71xn1fmd4qqg2wshml
14 Aug 23
Other Events
8:00am
8-K
EX-99.1
i4k6nltmq4 7hm9
1 Jun 23
June 2023 Larimar Therapeutics Corporate Presentation
4:06pm
8-K
EX-99.2
0munrqql5qj 7s
10 Nov 22
Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
7:01am
8-K
EX-99.1
s3ul512gjsgf445
20 Oct 22
October 2022 Larimar Therapeutics Corporate Presentation
8:11am
424B5
vn1 o92dvipvpgec0
14 Sep 22
Prospectus supplement for primary offering
7:28am
8-K
EX-99.2
a8z9 y3dd4
14 Sep 22
Other Events
7:05am